Stockreport

Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php
PDF ORLANDO, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced today that it will be presenting at the 4th Annual Immuno-Onco [Read more]